Staphylococcal infection and neutrophilic inflammation can act in concert to establish a profoundly hypoxic environment. In this review we summarise how neutrophils and Staphylococcus aureus are adapted to function under hypoxic conditions, with a particular focus on the impaired ability of hypoxic neutrophils to effect Staphylococcus aureus killing.
Principal effector functions of neutrophils
Neutrophils are the major cellular arm of the innate immune system and the first line of defence against invading micro-organisms. They recognise and eliminate pathogens rapidly and effectively by a range of cytotoxic mechanisms, and also modulate the wider host response, recruiting other immune cells and amplifying inflammatory cascades. Neutrophils comprise 50%e70% of circulating leukocytes but have a short circulating half-life, necessitating a bone marrow generation rate of 10 11 per day, increasing to up to 10 12 per day during bacterial infections [1] . Neutrophil homeostasis is maintained through a delicate balance of granulopoiesis, bone marrow release, margination in intravascular pools, tissue recruitment, and cell death and destruction [2] .
In health, circulating neutrophils are quiescent but, in disease states, exposure to priming agents, such as platelet activating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF) or bacterial lipopolysaccharide (LPS), renders them more responsive to recruitment and activation signals. Priming also augments pathogen entrapment and killing mechanisms, including chemotaxis, phagocytosis, granule exocytosis, production of reactive oxygen species (ROS) and release of neutrophil extracellular traps (NETs). Primed neutrophils in the systemic circulation have been identified in disease states, such as bacterial sepsis, and in addition to their augmented bactericidal capacity they may contribute to disease pathogenesis [3] .
Extravasated neutrophils migrate towards sites of inflammation and infection down chemoattractant concentration gradients, a process termed chemotaxis. Chemoattractant control of neutrophil migration is complex, not least because the effect on chemotaxis may depend on agonist concentration and context, but also the in vivo milieu is a dynamic environment comprising multiple chemokine signals. There is intracellular signalling hierarchy, with end-target chemoattractants signalling predominantly through p38 MAPK [4] . Neutrophils are avid phagocytes, which recognise and rapidly ingest bacteria. Target particles are engulfed into the phagosome, a plasma membrane-derived vacuole formed by extension of neutrophil pseudopods. Phagocytic receptor ligation initiates phosphorylation cascades, enabling pseudopod extension by means of dynamic changes in the actin cytoskeleton (reviewed in Ref. [5] ). As phagosomes mature, they acquire microbicidal activity by fusion of additional components, including cytosolic granules which contain abundant proteases and antimicrobial peptides.
Although they comprise a spectrum, granules are classified by their protein content: azurophilic granules are rich in myeloperoxidase (MPO), defensins and serine proteases including neutrophil elastase (NE), cathepsin G and proteinase 3; specific granules contain abundant lactoferrin and matrix metalloproteinase-8 (MMP-8); whilst the exemplar protein of gelatinase granules is MMP-9. Specific and gelatinase granules also contain p22 phox and gp91 phox , the membrane subunits of NADPH oxidase, which enable ROS production [6] . As well as having antimicrobial effects, external release of proteases can degrade the extracellular matrix, enabling neutrophil transit through host tissues but also contributing to tissue injury.
Generation of ROS through activation of the NADPH oxidase electron transport chain plays a critical role in the killing of several bacterial and fungal pathogens. NADPH oxidase is an electron donor, which reduces molecular di-oxygen to form superoxide anion, yielding an array of antimicrobial ROS. The dramatic increase in oxygen consumption associated with ROS production is termed the respiratory burst. Patients with chronic granulomatous disease, a rare genetic disorder caused by a defective NADPH oxidase complex, are unable to mount an effective respiratory burst and consequently suffer severe recurrent infections with fungi, such as Aspergillus, and several species of bacteria, including Staphylococcus aureus [7] . There is a complex interplay between ROS, granulederived proteases and proteins, and pH in the phagosome, and the contribution of each component to pathogen killing varies between organisms.
NETs are expulsions of decondensed chromatin, beaded with antimicrobial proteins and proteases, into the extracellular space; NET formation is stimulated by pro-inflammatory mediators, including tumour necrosis factor-a (TNF-a) and pathogen-associated molecular patterns [8] . NETs adhere to various pathogens in vivo, and may facilitate killing of organisms that are too large to be ingested [9] , but it has been postulated that this attachment may be utilised by certain organisms to form biofilms, and may induce direct tissue damage [10] . There is also conflicting evidence for a direct microbicidal effect of NETs [8, 11] .
Neutrophils undergo constitutive apoptosis, resulting in short survival times; however, apoptosis can be delayed at sites of inflammation by both signals from the host, e.g. GM-CSF, and bacteria, e.g. LPS [12] . In order to limit host tissue damage from dying cells, efferocytosis safely disposes of potentially histotoxic neutrophil contents and also inhibits macrophage pro-inflammatory cytokine production, hastening the resolution of inflammation (reviewed in Ref. [13] ).
Apoptosis can be initiated through the extrinsic pathway (ligation of cell surface death receptors such as FAS), or through the mitochondrial-driven intrinsic pathway. Electron microscopy studies identify comparatively few mitochondria in neutrophils, but fluorescent dyes have revealed a complex mitochondrial network which controls cell fate by releasing pro-apoptotic proteins, such as cytochrome c, into the cytosol [14] . Bioenergetic profiles and inhibitor studies have demonstrated that neutrophils rely almost entirely on glycolytic respiration for energy production, rather than oxidative phosphorylation, and that the respiratory burst is independent of mitochondrial respiration [15] . Hence, these organelles in neutrophils contribute very minimally to ROS production and molecular oxygen consumption, with the predominant function being regulation of cell death.
Neutrophils can also influence other immune cell populations. They can release both pro-and anti-inflammatory cytokines in an agonist-dependent manner [16] , secrete products such as defensins and cathelicidins which induce CD4 þ and CD8
þ T cell chemotaxis [17] , and acquire certain properties of antigen presenting cells [18] . Although these attributes confer a more complex, flexible and environmentspecific role than previously appreciated, the key neutrophil function remains host defence against invading pathogens, and when this function is significantly compromised, severe infection is more likely.
Relevance of hypoxia to neutrophils
Neutrophils are generated within the bone marrow, a significantly hypoxic microenvironment even under healthy physiological conditions, with murine in vivo measurements of local oxygen tension recorded as low as 1.3 kPa [19] . Indeed, within the bone marrow structure, haematopoietic stem cells are found sequestered in regions staining most strongly for the hypoxia probe pimonidazole, a 2-nitroimidazole compound, which forms covalent bonds with cellular macromolecules at oxygen levels below 1.3 kPa. Taken together with the evidence that low oxygen tensions favour the maintenance of haematopoietic stem cells in culture [20] , hypoxia appears to play a critical role in neutrophil development.
Once released from the bone marrow, mature circulating neutrophils are exposed to a wide range of oxygen tensions, transiting rapidly from a pO 2 of 13 kPa in main systemic arteries, to 7 kPa in arterioles and 3e4 kPa in capillaries and venules. Given the oxygen diffusion limit from capillaries of 80e140 mm, the oxygen tension in normal tissues is often even lower, generating so called "physiological hypoxia". Along with the bone marrow, physiological hypoxia has been demonstrated in tissues such as healthy muscle and connective tissue [21] , colonic epithelium [22] and, intriguingly, even in the skin [23] , despite being in such close proximity to air. This relative lack of molecular oxygen can be further amplified in pathological conditions, such as organ inflammation or ischaemia, and within solid tumours, due to damaged vasculature, compartmentalisation of infection, and high metabolic activity and oxygen requirements of pathogens and host cells. Hypoxia has been demonstrated in numerous pathological environments through in vitro and in vivo sampling: by microelectrode pO 2 measurement of wounds and venous ulcers [24] ; by blood gas analysis of abscesses, a characteristic feature of staphylococcal infection [25] ; by staining for hypoxia inducible factor (HIF), which increases exponentially below 6% oxygen, in chronic obstructive pulmonary disease [26] ; by pimonidazole staining in pulmonary infection [27] ; and by luminescence-based in vivo optical imaging in skin infection [28] . Interestingly, in a murine model of acute colitis, neutrophils actively contributed to the hypoxic microenvironment by depletion of molecular oxygen through NADPH oxidase activity and, hence, induced stabilisation of epithelial HIF [29] . Furthermore, Staphylococcus aureus was shown to deplete oxygen in a skin infection model, and biofilm-induced oxygen demand made the underlying dermal tissue anoxic [30] . Hypoxia impedes wound healing, and has been shown to impair clearance of inhaled S. aureus, though not Proteus mirabilis, in a mouse model of lung infection [31] . Moreover, supra-physiological levels of oxygen can promote resolution of certain infections [32] .
Oxygen sensing by neutrophils
As neutrophils are the frontline cells involved in host defence in most hypoxic environments, it is vital that these cells have the capacity to function effectively at low oxygen levels. Neutrophil adaptation to hypoxia is critically dependent upon the HIF/PHD pathway ( Fig. 1 ). HIF is a heterodimeric protein comprising a and b subunits, with degradation of HIFa subunits mediated by prolyl hydroxylase domain-containing enzymes (PHDs) [33] . These oxygen-sensitive hydroxylase enzymes are inhibited under hypoxia and, thus, hypoxia facilitates the accumulation of HIF-a subunits, which dimerise with HIF-b (ARNT) and bind to hypoxia response elements on target genes. Further regulation of HIF transcriptional activity is provided by factor inhibiting HIF (FIH), which hydroxylates an asparaginyl residue, preventing interaction with HIF coactivators and further repressing HIF-mediated transcription [34] (Fig. 1) .
Of the 3 known HIF-a subunits, neutrophils express both HIF-1a and HIF-2a mRNA, and both proteins are stabilized in hypoxia and when these cells are exposed to inflammatory stimuli, such as LPS and streptococci [35] . HIF-1a and HIF2a regulate distinct but overlapping target gene sets, with HIF1a having a greater impact upon immediate metabolic targets. In hypoxic culture, neutrophils upregulate glycolytic HIF-1a target genes, such as glyceraldehyde 3-phosphate dehydrogenase and phosphoglycerate kinase [36] . Indeed, neutrophils deficient in HIF-1a have reduced ATP levels even under normoxic conditions, reflecting the importance of HIF-1a in the regulation of neutrophil energetics [37] . It is therefore not surprising that HIF-1a is essential for extended neutrophil survival in hypoxia [36] . Notably, deficiency of HIF-2a impairs neither neutrophil survival in hypoxia nor key neutrophil functions, suggesting that HIF-2a plays a less prominent role in the control of hypoxic neutrophil responses. Nonetheless, HIF-2a does appear to regulate neutrophil lifespan in the context of inflammation; lower expression of the antioxidant enzyme catalase in HIF-2a deficient neutrophils compared to wildtype cells was associated with increased apoptosis in response to nitrosative stress, and enhanced inflammation resolution in a model of acute lung injury [35] .
Neutrophils express 3 isoforms of PHD enzymes (PHDs1-3). Hypoxia significantly upregulates PHD3 in a HIF-1a dependent manner. Loss of PHD3 does not alter induction of Fig. 1 . In normoxic environments, prolyl hydroxylase-containing enzymes (PHDs) mark HIF-a for ubiquitination and proteasomal degradation via the von Hippel Lindau (vHL) protein complex. Factor inhibiting HIF (FIH) inactivates HIF-a transcription by asparginyl hydroxylation, preventing binding of transcription cofactors. PHDs and FIH display an absolute requirement for dioxygen, Fe(II), ascorbate and 2-oxoglutarate. In hypoxic environments, reduced hydroxylase activity due to the lack of molecular oxygen allows stabilisation of HIF-a which translocates to the nucleus and binds HIFb. The HIF heterodimer binds hypoxia response elements (HRE), upregulating transcription of hypoxia-responsive genes.
HIF-1a target genes in hypoxic neutrophils but is necessary for cell survival in hypoxic conditions, suggesting that these pro-survival effects are mediated independent of HIF-1a in neutrophils [38] . Interestingly, under hypoxia PHD3 deficiency only impacted on neutrophil apoptosis, with other effector functions, such as phagocytosis, chemotaxis and the respiratory burst, being unaffected. Specific roles of the other PHD enzymes in neutrophils still require elucidation but, given the distinct functions for PHD3 observed in macrophages [39] , may well be of interest. PHD enzymes belong to a wider family of 2-oxoglutarate-dependent oxygenases including the Jumonji histone demethylases. In hypoxic macrophages, transcription of specific cytokines was suppressed due to increased methylation of promoter region histone H3 residues as a result of demethylase inhibition [40] ; these enzymes have not been studied in the neutrophil.
Crosstalk between the HIF pathway and nuclear factor kappa-light-chain enhancer of activated B cells (NFkB) adds a further layer of complexity to oxygen sensing in neutrophils. HIF1A mRNA levels are regulated by members of the NFkB pathway via the binding of NFkB to the HIF1A promoter. This is likely to be of particular importance in inflammatory microenvironments as it provides a mechanism by which stimuli such as LPS and TNF-a can influence basal transcription and induction of HIF1A mRNA in myeloid cells. Hypoxic induction of NFkB is in turn regulated by HIF-1a, with evidence of reduced induction of the NFkB components IKKa, IKKb and p65 in HIF-1a deficient neutrophils [36] .
Hypoxic effects on neutrophil functions

Apoptosis
Ingestion of S. aureus induces neutrophil apoptosis, which then progresses rapidly to necrosis and may contribute to pathogen virulence [41] . Hypoxia modulates the neutrophil apoptotic threshold, delaying constitutive apoptosis in a concentration-dependent and reversible manner via HIF-1a mediation of NFkB signalling. This hypoxic survival effect can be prevented by NFkB inhibitors, and is diminished in HIF-1a-deficient murine neutrophils [36] . Further evidence for a pro-survival effect of HIF-1a is provided by the delayed apoptosis of human neutrophils observed when HIF is stabilised, either by loss-of-function mutations in von Hippel Lindau (vHL) protein (which targets HIF-1a for degradation) [42] , by exposure of healthy volunteers to acute hypoxia [43] , or by pharmacologic or genetic manipulation of HIF-1a in zebrafish [44] . Similarly, intermittent hypoxia delayed apoptosis of TNF-a-treated human neutrophils [45] , and neutrophils isolated from patients with obstructive sleep apnoea, which is characterised by intermittent hypoxia/reoxygenation, exhibited delayed apoptosis and increased expression of the adhesion molecule CD15 [46] . Hypoxia increases b 2 integrin protein expression, which is again mediated by HIF-1 [47] , and may contribute to the hypoxic survival effect; b 2 integrin clustering or activation with endothelial ligands, such as ICAM-1, delays apoptosis through AKT and MAPK-ERK signalling, although b 2 integrin activation in the presence of death-inducing agonists, such as TNF-a, can also accelerate apoptosis.
Two further mediators of hypoxic neutrophil survival have been identified. Firstly, MIP-1b is secreted by hypoxic granulocytes and confers a survival effect when co-incubated with normoxic neutrophils [36] . Secondly, PHD3 is upregulated by hypoxia and prolongs neutrophil survival independent of HIF1a by suppression of the pro-apoptotic factor Siva-1. The impact of hypoxia-mediated neutrophil survival is context dependent; PHD3-deficient mice exhibited accelerated neutrophil apoptosis and enhanced resolution of sterile inflammation (ALI and colitis models) [38] , but displayed increased mortality (thought to reflect aberrant macrophage function) when challenged with abdominal sepsis [39] .
Adhesion, transmigration, chemotaxis and recruitment
Firm adhesion of neutrophils to endothelium prior to transmigration is mediated by the interaction of neutrophil b 2 integrins with endothelial ligands, such as ICAM-1. Multiple studies support a hypoxia-mediated increase in b 2 integrin expression (e.g. Ref. [47] ) with only one report (where reoxygenation was permitted after neutrophil isolation) finding no difference [44] . Although reports of modulation of ICAM-1 expression by hypoxia are conflicting [48, 49] , several studies have shown increased neutrophil adhesion to the endothelium under hypoxia (e.g. Ref. [50] ). Studies of neutrophil transmigration under hypoxia have also shown an increase. Hypoxia enhanced neutrophil transmigration in vitro in a model of intestinal epithelium ischaemia-reperfusion [51] and in vivo in rodent models of acute systemic hypoxia when assessed in multiple organs by intravital microscopy [52] or by quantification of MPO [53] . However, the reported effects of hypoxia on chemotaxis are variable. Extravasated neutrophils undergo shape change to a polarised morphology, which is essential for directional movement. McGovern et al. showed no change in IL-8-induced shape change, or chemotaxis towards IL-8, bacterial formylated peptide (fMLF) or LPS in human neutrophils cultured under hypoxia [54] , and, likewise, Peyssonnaux et al. found no difference in chemotaxis towards fMLF through an endothelial monolayer between wildtype, HIF-1a null and vHL-null murine neutrophils [55] . In contrast, Wang and Liu showed enhanced chemotaxis of neutrophils isolated from hypoxic subjects [56] , whereas Rotstein et al. showed reduced chemotaxis of human neutrophils towards fMLF and zymosan-activated serum under hypoxia in an agarose gel migration assay [57] . The different findings in these studies are likely due to variation in assay type, particularly the use of true hypoxia versus HIF-1a manipulation, and the effects of re-oxygenation of cells prior to assays. It is also unclear how well these in vitro assays represent the true physiological environment with its multitude of signals, and studies of true neutrophil recruitment under normoxia or hypoxia, a composite outcome of adhesion, transmigration and chemotaxis, have yielded conflicting results. Tissue neutrophil infiltration in a murine model of chemical irritant-induced cutaneous inflammation was significantly reduced in a myeloid HIF-1a knockout mouse model at 24 h, whereas vHL deletion promoted infiltration [37] . Likewise, pharmacological HIF-1a stabilisation enhanced tissue neutrophil recruitment in mice treated with intradermal LPS [58] . Conversely, pharmacological HIF-1a stabilisation has been shown either to diminish neutrophil recruitment (in murine uropathogenic Escherichia coli bladder infection) [59] , or to have no impact (in murine S. aureus skin infection) [60] . Recruitment of wildtype, HIF-1a-null or vHL-null neutrophils in a mouse model of group A Streptococcus ulcer was comparable up to 24 h [55] . Similarly, in a mouse model of Pseudomonas aeruginosa keratitis, HIF1a siRNA knockdown did not affect neutrophil recruitment at 24 h, although by day 5 there was increased tissue neutrophil infiltration [61] . The inconsistencies between these studies may be explained by variations in time, species, induction agent and tissue site, or they may reflect the fact that hypoxia does not equate precisely to HIF stabilisation. Overall, there is currently no clear or consistent picture of how hypoxia affects neutrophil recruitment in vivo, and any effects are likely to be highly context-dependent.
Phagocytosis
On reaching a site of infection, neutrophils must employ their myriad killing mechanisms. Neutrophils obtained from acutely hypoxic volunteers (whole blood or purified cells) showed enhanced phagocytosis of zymosan [62] and E. coli, with enhanced expression of opsonic (FCgIIIbR) and complement (C1qRp and C5aR) receptors [56] , which are important for pathogen recognition and ingestion. Interaction with matrix proteins further increased FCgR expression in the setting of hypoxia [63] , which may reflect the in vivo environment more accurately. Likewise, phagocytosis of zymosan by neutrophils isolated from rabbits after experimental acute ischaemia [64] , phagocytosis of E. coli by neutrophils isolated from hypoxic pre-conditioned rats [65] and phagocytosis of S. aureus by neutrophils isolated from volunteers exposed to intermittent hypoxia [66] were all increased. These in vitro assays were performed under normoxic conditions; however, similar results were obtained using isolated human neutrophils with in vitro assays performed under hypoxia [67] . Further evidence that hypoxia-induced signalling pathways can increase phagocytosis is provided by neutrophils from patients with heterozygous mutations in vHL protein, which display enhanced phagocytosis of Streptococcus pneumoniae under normoxia, further augmented by hypoxia [42] . The same group found that neutrophils from healthy volunteers incubated under hypoxia had enhanced CD11b expression but that phagocytosis of S. pneumoniae was not increased [54] . However, the majority of studies suggest that neutrophil phagocytosis is increased by hypoxia.
Reactive oxygen/nitrogen species
Data regarding the effects of oxygen availability on ROS production are conflicting. Studies of neutrophils isolated from human volunteers or mice exposed to hypoxia have shown an increase in ROS production [44, 56, 65] , although, of note, all cell isolation and in vitro assays were conducted under normoxic conditions. Whilst HIF-1a manipulation did not affect ROS release [55, 60] , in vitro assays conducted under hypoxia have consistently shown decreased intracellular and extracellular superoxide anion production, restored by re-oxygenation [54] and further increased under hyperbaric oxygen conditions. Moreover, intermittent hypoxia and its clinical correlate obstructive sleep apnoea appear to prime neutrophils for augmented superoxide anion generation [68] . Together these data suggest that ROS production depends on oxygen availability, and that the decrease seen under hypoxic conditions is likely due to a lack of molecular oxygen, which is not recapitulated by modulation of HIF-1a signalling. Microbicidal activity of ROS is highly context-dependent and varies with bacterial species; ROS production contributes significantly to S. aureus killing whereas E. coli killing is predominantly oxidase-independent [54, 69] . In addition to ROS, neutrophils produce antimicrobial reactive nitrogen species, a process which does appear to be under HIF-1a control. In a zebrafish mycobacterial infection model, stabilisation of HIF-1a increased production of reactive nitrogen species via inducible nitric oxide synthase (iNOS), decreasing mycobacterial burden [70] .
Granule exocytosis
A clear consensus has emerged that hypoxia increases the release of neutrophil antimicrobial peptides and proteases. As such, hypoxia enhanced the release of multiple granule products, including MMP-9, lactoferrin and active NE and MPO from stimulated human neutrophils [71] . HIF-1a siRNA knockdown reduced protein levels of murine b-defensins and cathelicidin-related antimicrobial peptide (analogous to human antimicrobial peptide LL-37) in a mouse model of pseudomonal infection [61] . Similarly, HIF-1a null human neutrophils exhibited reduced NE and cathepsin G activity and displayed a marked reduction in active cathelicidin expression, with the opposite true of vHL-deficient neutrophils [55] . Moreover, pharmacological stabilisation of HIF-1a upregulated the genes encoding LL-37 in human neutrophils [72] . Enhanced degranulation may promote tissue injury and cavity formation; staphylococcal abscesses are associated with a massive influx of neutrophils, and MMPs have been implicated in mycobacterial cavity formation [73] . However, neutrophil proteases might also enhance phagocyte access to sites of infection and, hence, aid extracellular killing.
Neutrophil extracellular traps
There have been few studies into the effect of hypoxia on NETosis and, to date, the data are variable. Pharmacological stabilisation of HIF-1a had no observed effect on NET production but increased S. aureus killing in vitro, even in the presence of a phagocytosis inhibitor, an effect which was abrogated by the addition of deoxyribonuclease [60] , suggesting that killing was NET-dependent. Consistent with these results, pharmacological and genetic HIF-1a knockdown decreased NET production and inhibited extracellular bacterial killing [74] . However, in vitro NET formation under true hypoxia has been shown to be diminished [71] . As NETosis is predominantly dependent on NADPH production of ROS [75] , and therefore reliant on availability of molecular oxygen, it seems likely that NET production under hypoxia would be reduced in line with the ROS data, though it appears that HIF1a signalling also has a role to play. Furthermore, other cells in a hypoxic environment may also impact on neutrophil function; for example, in a mouse hepatic tumour model, neutrophils incubated with media from hypoxic tumour cells showed increased NETosis, and this was associated with increased metastatic disease [76] .
In summary, hypoxia appears to inhibit neutrophil apoptosis, enhance degranulation and the release of antimicrobial products, and promote phagocytosis, but reduce ROS and NET production. However, despite increased adhesion of neutrophils to endothelium in hypoxia, the effect on recruitment to sites of infection is less certain, context-dependent, and requires further investigation.
Hypoxic effects on S. aureus and its killing by neutrophils
S. aureus is a virulent and versatile pathogen, which causes significant morbidity. Mortality rates following staphylococcal bacteraemia are increasing, and methicillin resistant S. aureus (MRSA) bacteraemia has a higher case fatality record than methicillin-sensitive strains [77] . Approximately 30% of the population is colonised with S. aureus, and yet in healthy individuals this usually has no pathological significance; however, in some situations there is a major risk of invasive disease, particularly in vulnerable populations such as the elderly or immunocompromised, and those with skin barrier breaches or impaired mucosal immunity. Prosthetic joints, heart valves and other indwelling devices are a particular risk for the development of deep-seated infection and provide a reservoir of staphylococcal infection that is extremely challenging to eliminate. Clinical manifestations of S. aureus infection include local tissue destruction and abscess formation, and haematogenous dissemination, resulting in infections such as osteomyelitis, endocarditis and pneumonia.
The importance of neutrophils in host defence against S. aureus infection is well illustrated by patients with defects in neutrophil number and/or function. The critical neutrophil concentration, where bacteria multiply and are phagocytosed at the same rate, has been determined for S. aureus as 400,000 neutrophils/ml [78] , similar to the clinically relevant concentration of 500,000 neutrophils/ml, below which neutropaenic patients are at high risk of severe pyogenic bacterial infection. Furthermore, patients with severe congenital neutropaenia, leucocyte adhesion deficiency (impaired endothelial transmigration), ChediakHigashi syndrome (impaired chemotaxis and degranulation) and chronic granulomatous disease (defective ROS production), all suffer from recurrent staphylococcal infections [79] .
S. aureus has evolved extensive virulence mechanisms, which aim to evade neutrophil killing, including inhibition of neutrophil chemotaxis and extravasation, strategies to evade phagocytosis, disarmament of antimicrobial peptides and proteases, removal of anti-oxidants, degradation of NETs and direct lysis of neutrophils by secreted leukotoxins. This subject has been extensively reviewed [80] , and further details are beyond the scope of this review. Despite being considered classically an extracellular pathogen, S. aureus has been shown to survive within the phagosome, and transfer of neutrophils containing viable intracellular bacteria to a naïve animal can institute infection [81] . Given the diversity of staphylococcal virulence mechanisms, which are intrinsically linked to neutrophil attack and evasion, it is important to note that there are a large number of S. aureus clinical isolates and laboratory strains used experimentally, and commonly used strains frequently carry significant mutational alterations in regulatory genes. For example, S. aureus strain NCTC8325, isolated from a historic sepsis patient and now maintained as the laboratory strain RN1, is fully antibiotic sensitive and also defective in two regulatory genes, one of which encodes a transcription activator of virulence factor protein A. In comparison, USA300 is a virulent community-acquired MRSA clinical isolate with high haemolytic activity and leukotoxin secretion [82] . Hence, it is conceivable that variations between strains used experimentally may underlie some of the conflicting results.
S. aureus infection often establishes a hypoxic environment; for example staphylococcal biofilms induce hypoxia in dermal tissue, impairing wound healing [30] . A second example relates to osteomyelitis; healthy bone is intrinsically hypoxic, and further decreases in skeletal oxygen concentration upon S. aureus infection were revealed by intravital oxygen monitoring [83] . Hence, S. aureus must possess flexibility in order to survive in hypoxic environments. Bacteria can adapt to hostile environments via two component histidine kinase systems. Transposon sequencing in a murine model of S. aureus osteomyelitis identified the staphylococcal respiratory response two component system SrrAB as essential for hypoxic survival, co-ordinating an increase in quorum sensing-dependent exotoxin production, which enhanced in vitro human osteoblast cytotoxicity [83] . Infection with an SrrA mutant decreased staphylococcal growth in vivo although, interestingly, the growth defect was rescued by depletion of neutrophils, suggesting that S. aureus requires SrrAB to resist hypoxic stress imposed by neutrophils. Targeted mutations have shown that SrrAB is activated by hypoxia and required for staphylococcal growth in a hypoxic static biofilm [84] . However, SrrAB control of virulence in hypoxia seems context specific as over-expression of SrrAB in a rabbit model of S. aureus endocarditis repressed virulence factors [85] .
It is fascinating to consider how hypoxia influences S. aureus infection, as both bacteria and neutrophils appear well adapted to function in this environment and both may induce hypoxia in the surrounding tissues. Some studies have suggested that hypoxia restricts S. aureus infection. Pharmacological stabilisation of HIF-1a with two different agonists increased the bactericidal capacity of human neutrophils against S. aureus in vitro, and limited S. aureus proliferation and lesion formation in mouse skin infection [60, 72] . Hypoxia increased S. aureus killing by stimulated human neutrophils in vitro [67] , and neutrophils isolated from subjects exposed to intermittent hypoxia had enhanced bactericidal activity against S. aureus [66] . However, whether HIF-1a stabilisation reflects true hypoxia is debatable as S. aureus was not subjected to low oxygen tensions in these models and may therefore be more susceptible. Furthermore, it is not clear whether the in vitro experiments were conducted under hypoxia or after re-oxygenation; for example, in one such study [67] , neutrophils were rendered hypoxic by circulating blood in a gas-permeable silicon circuit against an anoxic gas mixture, but no mention was made of how (or if) hypoxia was maintained during the subsequent 4 h killing assay.
In fact, the majority of the literature suggests that hypoxia impairs S. aureus killing by neutrophils. Hypoxia reduced the ability of neutrophils to kill S. aureus in vitro (e.g. Ref. [86] ), increased the size of S. aureus lesions in dog and rabbit skin infection models [32, 87] , and impaired clearance of S. aureus from the lung in rodent pneumonia models (e.g. Ref. [31] ). Furthermore, pharmacological HIF-1 inhibition increased survival in a mouse model of S. aureus peritonitis [88] .
Effective S. aureus killing is predominantly dependent on ROS production [69] . A number of in vitro studies have suggested that impaired ROS generation in hypoxia accounts for decreased bactericidal activity of neutrophils against S. aureus; the degree of phagocytosis has not been found to be diminished [54, 86] . McGovern et al. showed that hypoxia markedly reduced both ROS generation and S. aureus killing, and, interestingly, observed an intracellular bacterial survival advantage when S. aureus was incubated with neutrophils under hypoxia [54] . They proposed that reduced ROS production was due to the lack of molecular oxygen as hypoxia did not change the expression of NADPH oxidase subunits; although challenging to interrogate NADPH oxidase assembly directly, addition of pyocyanin (which oxidases intracellular NADPH, NADH and reduced glutathione) did not increase ROS generation under hypoxia, indicating that the hypoxic effect on ROS production was independent of NADPH. Furthermore, in this study, a brief (15 min) period of reoxygenation restored both ROS formation and bactericidal capacity. Inhibition of neutrophil ROS production by selective inhibitors of p38 and p44/42 MAPK has also been shown to decrease S. aureus killing, although these inhibitors additionally reduced mobilisation of b 2 integrin to the plasma membrane, which may have contributed to the effect [89] . Neutrophils isolated from patients suffering recurrent pyogenic infections showed a strong correlation between impaired S. aureus killing and reduced superoxide anion production [90] , and neutrophils from patients with chronic granulomatous disease (where ROS generation is absent) had significantly impaired ability to kill S. aureus [32] . Furthermore, neutrophil oxidants were able to inhibit a S. aureus quorumsensing virulence-inducing peptide, a control mechanism which may be lost in hypoxia [91] .
The prevailing view of the role of ROS in bacterial killing has been that the generation of highly toxic oxidants in the presence of MPO have a direct microbicidal effect; superoxide generated by NADPH oxidase dismutates to yield H 2 O 2 , a substrate for MPO, which then catalyses the oxidation of halides, the most important and cytotoxic being hypochlorous acid (HOCl). Recently this scheme has been challenged: Segal and colleagues have suggested that the primary role of NADPH oxidase is electron delivery to the phagosome, which is compensated by an influx of potassium ions, alkalinising the vacuolar pH so that it is optimal for antibacterial protease activity [92] . They argue that oxidant production is a byproduct, with MPO acting as a scavenger to protect proteases from oxidant damage and inactivation, and in fact inhibiting bacterial killing by H 2 O 2 at physiological pH. However, Green et al. still maintain that HOCl is instrumental in bacterial killing, demonstrating that decreased chlorination in the phagosome halved killing of S. aureus [93] . HOCl production was predominantly localised to the phagosome and, although a significant amount reacted with phagosomal proteins prior to microbial contact, there was sufficient HOCl to be directly microbicidal. Indeed, modifications of host proteins by HOCl may provide further active species, such as chloramines, which could extend microbial killing. Whether ROS act directly or indirectly in this regard, there is considerable in vitro evidence that the lack of ROS generation in hypoxia substantially reduces S. aureus killing.
The role of neutrophil proteases in host defence against S. aureus under hypoxia is unclear. Hypoxia enhances neutrophil degranulation, and the granule protease cathepsin G appears to be particularly important for S. aureus killing; mice lacking cathepsin G had increased mortality in a peritoneal sepsis model [92] . However, NE did not kill S. aureus directly, NEnull neutrophils killed S. aureus as well as wildtype cells in vitro, and mice lacking NE actually had a survival benefit in S. aureus sepsis [94] , possibly due to excess damage of host tissues by NE in wildtype mice, which may be further increased in hypoxia.
Controversy surrounds the role of NETs in S. aureus killing. Whether NETs kill [8, 95] or merely trap [11] S. aureus, it seems likely that a reduction in NETosis under hypoxia (as discussed in Section 4.6.) would allow Staphylococcus to thrive. Moreover, NET-associated S. aureus had decreased amounts of a toxin when compared with free bacteria, suggesting that NETs have a potential role in controlling S. aureus by degrading virulence factors [8] . However, S. aureus has been shown to degrade NETs in vitro and these degradation products can induce macrophage apoptosis [96] . At this stage, the role of NETs in hypoxic environments and their interaction with other cells of the immune system remains speculative.
In summary, the majority of the literature supports defective killing of S. aureus under hypoxic conditions, both in vitro and in vivo, predominantly due to impaired ROS production (Fig. 2) . The role of antimicrobial proteases and NETosis in hypoxic staphylococcal killing is not well established and invites further investigation.
Conclusion
Neutrophils and S. aureus are often found in profoundly hypoxic environments where both must function effectively, each striving for dominance. At first appearance, it seems that neutrophils are well adapted to hypoxia, with reliance on anaerobic energy production, prolonged survival, and augmented phagocytosis and degranulation. However, S. aureus has evolved numerous strategies to evade neutrophil killing and this evasion is further enhanced by hypoxia, where lack of molecular oxygen significantly impairs neutrophil ROS production and, hence, staphylococcal killing. Currently, S. aureus appears to be winning the hypoxic battle. Modulation of the hypoxic neutrophil response is certainly worthy of future investigation to see if the balance can be tipped.
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